2015
DOI: 10.1016/j.micpath.2015.07.009
|View full text |Cite
|
Sign up to set email alerts
|

The effects of d-Tyrosine combined with amikacin on the biofilms of Pseudomonas aeruginosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 32 publications
0
30
0
Order By: Relevance
“…Thus, the use of disassembling agents is considered a good strategy to enhance the therapeutic potential of AMPs and other antimicrobials against mature biofilms. A number of compounds including lytic enzymes, furanones, triterpenes and D-amino acids have shown ability to disassemble the biofilm structure [ 46 , 47 , 48 , 49 ]. In this study, we used as potentiating agent the cation chelator EDTA.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, the use of disassembling agents is considered a good strategy to enhance the therapeutic potential of AMPs and other antimicrobials against mature biofilms. A number of compounds including lytic enzymes, furanones, triterpenes and D-amino acids have shown ability to disassemble the biofilm structure [ 46 , 47 , 48 , 49 ]. In this study, we used as potentiating agent the cation chelator EDTA.…”
Section: Discussionmentioning
confidence: 99%
“…Effects of D-amino acids on B. subtilis may be simply due to toxic effects of inhibition of protein synthesis (48). Others have reported that mixtures of D-amino acids (49) or combinations of D-amino acids with antibiotics (50) may be more effective against biofilm formation than individual D-amino acids. Interpretation of these studies is complicated due to differences in strains, biofilm assays (for example, microtiter plate vs. flow-cell), and the dosage of specific D-amino acids used (51).…”
Section: Introductionmentioning
confidence: 99%
“…The clinical isolates utilized in this study were selected from a collection of clinical isolates of P. aeruginosa during January 2014 to December 2014 (She et al. ) from the Third Xangya hospital of Centre South University (Changsha, Hunan, China). No special ethical permit was required for this study according to the Chinese law.…”
Section: Methodsmentioning
confidence: 99%
“…Pseudomonas aeruginosa strain PAO1 (ATCC 15692) is a well-characterized wound isolate widely used as a laboratory strain (Holloway 1955;Schmidt et al 1996). The clinical isolates utilized in this study were selected from a collection of clinical isolates of P. aeruginosa during January 2014 to December 2014 (She et al 2015) from the Third Xangya hospital of Centre South University (Changsha, Hunan, China). No special ethical permit was required for this study according to the Chinese law.…”
Section: Bacterial Strains and Growth Mediamentioning
confidence: 99%